[Skip to Content]
[Skip to Content Landing]
Views 991
Citations 0
Editorial
June 11, 2020

Minimally Invasive Surgery for Gynecologic Cancers—A Cautionary Tale

Author Affiliations
  • 1Division Gynecologic Oncology, Department of Obstetrics and Gynecology, Stanford University, Stanford, California
JAMA Oncol. 2020;6(7):991-993. doi:10.1001/jamaoncol.2020.1617

The introduction of minimally invasive surgery (MIS) for the treatment of patients with cancer more than 2 decades ago generated enthusiasm as well as considerable concerns regarding its effectiveness and safety.1 Subsequent randomized clinical trials (RCTs) comparing laparoscopy with open surgery in colon and endometrial cancer reported fewer complications and shorter recovery times for laparoscopy vs open surgical procedures and no overall difference in survival between the 2 approaches.2-4 These trials provided reassuring evidence regarding the noninferiority of MIS to open procedures and were followed by a rapid adoption of MIS for the treatment of gynecologic cancers worldwide.

Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words
    ×